MK

Mohammed Kutty Cholakkal

Active Director Partner DIN 07621795
DIN 07621795 First appointment Dec 2016 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Dec 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammed Kutty Cholakkal

Data last updated:

Mohammed Kutty Cholakkal is a Partner at Dosage Hyper Pharma Llp (since 2023) and Director at Safa Institute Of Health Sciences Private Limited (since 2022). The companies operate in Pharma, Non-Profit Organizations and Metals and Minerals. Earlier, Mohammed Kutty Cholakkal was a Director at Khayar Enterprises Limited (2016–2017) and Director at Orchid Institute Of Healthcare And Research Private Limited (2017–2018).

DIN 07621795
Primary Designation Partner
Industry Pharma
First Appointment 28 Dec 2016
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner10 May 20232018Active
Director28 Mar 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Khayar Enterprises Limited U52520KL2016PLC047650
Director28 Dec 20162016Strike Off
Director19 Aug 20171996₹11.29 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Mohammed Kutty Cholakkal

Directorship timeline

Open interactive timeline →
Safa Institute Of Health Sciences Private Limited
Dosage Hyper Pharma Llp
Khayar Enterprises Limited
Orchid Institute Of Healthcare And Research Private Limited
Premium access

Shareholding and investment profile for Mohammed Kutty Cholakkal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammed Kutty Cholakkal

Mohammed Kutty Cholakkal currently holds 2 directorships: Dosage Hyper Pharma Llp (Partner, since 10 May 2023); Safa Institute Of Health Sciences Private Limited (Director, since 28 Mar 2022).

Mohammed Kutty Cholakkal was first appointed on 28 Dec 2016 as Director at Khayar Enterprises Limited. The most recent appointment on record is 10 May 2023 at Dosage Hyper Pharma Llp.

Mohammed Kutty Cholakkal held 2 earlier board appointments: Khayar Enterprises Limited (Director, 28 Dec 2016 to 20 May 2017); Orchid Institute Of Healthcare And Research Private Limited (Director, 19 Aug 2017 to 29 Mar 2018).

The current boards of Mohammed Kutty Cholakkal's companies include Faizal Babu Ambalancheeri (Dosage Hyper Pharma Llp), Mohammed (Dosage Hyper Pharma Llp), Mohammed Kalangadan (Safa Institute Of Health Sciences Private Limited), Sulthanali Chakkumkuth (Safa Institute Of Health Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available